OncoSenX
PrivateLast Round
VC Round
Aug 5, 2021
Total Funding Raised
$5.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OncoSenX is a biotechnology company that develops transient gene therapies designed to treat cancer. The company's therapy delivers a program that induces apoptosis in cancerous cells using a plasmid DNA delivered with a proteo-lipid vehicle that selectively kills cancerous cells based on their transcriptional activity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoSenX Comparables
Compare OncoSenX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oisín Biotechnologies | 79% | |
| Entos Pharmaceuticals | 76% | |
| BreezeBio | 68% | |
OncoSenX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 5, 2021 | ||||
| Series A | Apr 1, 2020 | ||||
| Pre Seed | Jul 8, 2019 | ||||
| Seed | Mar 14, 2019 |
Key People
Founding team and executive leadership
OncoSenX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helios Capital | VC Round |
| Althea | Pre Seed |
| Methuselah Foundation | VC Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM.
- May 18, 2026
Monthly visitors increased 105% MoM.
OncoSenX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoSenX's valuation, stock price, and market status.